Key result
Men carrying the apoB-100 EcoRI 13-kb allele had lower body fat but significantly higher adjusted plasma cholesterol levels (P<0.05) than 11-kb homozygotes.
Why the study?
Does the ApoB-100 gene EcoRI polymorphism influence the association between regional adiposity and plasma lipoprotein levels in healthy men?
Cross-Sectional (n=56)
Does the ApoB-100 gene EcoRI polymorphism influence the association between regional adiposity and plasma lipoprotein levels in healthy men?
The ApoB-100 EcoRI polymorphism influences the relationship between abdominal visceral adiposity and plasma cholesterol and apoB levels.
The apoB-100 EcoRI variant may link higher cholesterol to lower adiposity in men; hypothesis-generating and requires prospective confirmation before clinical consideration.
The aim of this study was to investigate whether the EcoRI restriction fragment length polymorphism (RFLP) of the apolipoprotein (apo) B-100 gene influences the associations described among obesity, regional adipose tissue distribution, and plasma lipoprotein levels. For this purpose, blood samples were collected from 56 healthy men for whom we had extensive measurements of regional adipose tissue distribution (both anthropometric and computed tomography-derived measurements) and data on the plasma lipoprotein-lipid profile. DNA was extracted from white blood cells, and RFLP analysis was performed. Subjects were classified into two groups on the basis of their apoB-100 EcoRI genotype: subjects homozygous for the major 11-kb allele, the 11/11 group (n = 40), and subjects carrying the minor 13-kb allele, the 13/11 group (n = 16). Subjects carrying the 13-kb allele had lower percent body fat and abdominal adipose tissue accumulation than subjects homozygous for the 11-kb allele (P < .05). Although leaner, the 13/11 group did not show a more favorable plasma lipoprotein-lipid profile than the group homozygous for the 11-kb allele. In fact, after statistical control for the difference in percent body fat between the two genotype groups, the 13/11 group showed significantly higher plasma cholesterol levels (P < .05) and nearly significantly higher apoB levels than the 11/11 group (P = .06). The association patterns between indices of regional adiposity and plasma cholesterol and apoB levels were also different between the two EcoRI genotype groups. Only in the 13/11 group was the abdominal visceral adipose tissue area significantly associated with these plasma variables.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Pouliot et al. (1994) conducted a cross-sectional in Healthy (n=56). apoB-100 EcoRI minor 13-kb allele (13/11 genotype) vs. apoB-100 EcoRI major 11-kb allele homozygotes (11/11 genotype) was evaluated on Plasma cholesterol levels after adjusting for percent body fat (p=<0.05). Men carrying the apoB-100 EcoRI 13-kb allele had lower body fat but significantly higher adjusted plasma cholesterol levels (P<0.05) than 11-kb homozygotes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: